PEBC Part I (MCQ) · Competency 1B Distribution (about 20%)
Distribution items test how a pharmacist assesses and processes prescriptions: completeness and validity, dose and interaction checks, look-alike names, dangerous abbreviations, labelling, substitution, transfers, refills and compliance packaging.
1B Distribution2 min read6 sections
Checked against the NAPRA Model Standards of Practice (2022); ISMP Canada Do Not Use list (2023) and look-alike/sound-alike list (2023); Narcotic Control Regulations and Food and Drug Regulations Part G; provincial pharmacy regulations; checked 13 Oct 2026. Not affiliated with or endorsed by The Pharmacy Examining Board of Canada (PEBC).
Expect intake scenarios with several prescriptions and a profile: identify the most important drug therapy problem, the correct action and what to document.
Allopurinol greatly increases azathioprine toxicity.
Opioid plus benzodiazepine increases sedation and falls.
Oxybutynin opposes donepezil (prescribing cascade).
Duplicate anticoagulation at discharge (warfarin plus enoxaparin).
Every note. Every question. One pass.
4 more sections of this note are part of Premium.
From about C$16.58/mo on the Until-you-pass pass (12 months)
Educational practice material for exam preparation only. Not medical advice and not a substitute for current product monographs, clinical guidelines or professional judgement. Questions have not yet been reviewed by a licensed pharmacist.